A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA (scientific article)

cites work (P2860)

Q33631612	17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha
Q34723651	7SK small nuclear RNA directly affects HMGA1 function in transcription regulation
Q24634280	7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription
Q30438975	9-Aminoacridine inhibition of HIV-1 Tat dependent transcription
Q27765139	A 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation
Q40740441	A Network of Regulations by Small Non-Coding RNAs: The P-TEFb Kinase in Development and Pathology
Q33793854	A Pipeline for Drug Target Identification and Validation
Q30274626	A Role of RNA Helicase A in cis-Acting Transactivation Response Element-mediated Transcriptional Regulation of Human Immunodeficiency Virus Type 1.
Q34139815	A bimolecular mechanism of HIV-1 Tat protein interaction with RNA polymerase II transcription elongation complexes
Q33802821	A block to human immunodeficiency virus type 1 assembly in murine cells
Q29547180	A chromatin landmark and transcription initiation at most promoters in human cells
Q45606075	A conditionally replicating virus as a novel approach toward an HIV vaccine
Q40256942	A high-throughput drug screening system for HIV-1 transcription inhibitors
Q28216031	A highly purified RNA polymerase II elongation control system
Q24561968	A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb
Q24302596	A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
Q39685470	A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells.
Q35155254	A naturally occurring substitution in human immunodeficiency virus Tat increases expression of the viral genome
Q24804709	A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation
Q28190014	A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter
Q40195173	A novel anticancer agent ARC antagonizes HIV-1 and HCV.
Q42689207	A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon
Q34391750	A nucleolar TAR decoy inhibitor of HIV-1 replication.
Q35107224	A nucleolus-predominant piggyBac transposase, NP-mPB, mediates elevated transposition efficiency in mammalian cells
Q40249131	A phenotypic recessive, post-entry block in rabbit cells that results in aberrant trafficking of HIV-1.
Q30479706	A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites
Q34621011	A role for CDK9-cyclin K in maintaining genome integrity
Q30321811	A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus
Q42039736	A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription
Q27334977	A single-molecule view of transcription reveals convoys of RNA polymerases and multi-scale bursting
Q29616120	A third-generation lentivirus vector with a conditional packaging system
Q27930899	A yeast heterogeneous nuclear ribonucleoprotein complex associated with RNA polymerase II
Q41172835	AF4 and AF4N protein complexes: recruitment of P-TEFb kinase, their interactome and potential functions
Q27683845	AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter
Q34052968	APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element
Q28203240	Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6)
Q44530421	Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation
Q24310643	Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription
Q24318644	Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells
Q24548503	Acetylation of histones and transcription-related factors
Q63351469	Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity
Q28375916	Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells
Q63351215	Activating Latent HIV by Inhibiting Bromodomain Proteins
Q34005293	Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1).
Q28115623	Activation of MyoD-dependent transcription by cdk9/cyclin T2
Q35746236	Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime
Q39606992	Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation
Q27936458	Activation of the cyclin-dependent kinase CTDK-I requires the heterodimerization of two unstable subunits
Q44040788	Amino acid modification in the HIV-1 Tat basic domain: insights from molecular dynamics and in vivo functional studies.
Q33930664	An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction
Q43634596	An RNA-binding chameleon
Q34289422	An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription
Q38163449	An integrated overview of HIV-1 latency
Q53615854	Analysis of U1 small nuclear RNA interaction with cyclin H.
Q33221255	Analysis of p300 acetyltransferase substrate specificity by MALDI TOF mass spectrometry
Q24527261	Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes
Q28257440	Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186
Q36632210	Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin
Q33836069	Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells
Q73138904	Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection
Q42796349	Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle
Q28292152	Antiviral activity of CYC202 in HIV-1-infected cells
Q37410634	Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat.
Q24672150	Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region
Q38906287	As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity
Q41641646	BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
Q24337878	BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II
Q35177820	BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection
Q27933584	BUR1 and BUR2 encode a divergent cyclin-dependent kinase-cyclin complex important for transcription in vivo
Q39591738	Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus
Q24563382	Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor
Q40563544	Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription
Q36777646	Bovine HEXIM1 inhibits bovine immunodeficiency virus replication through regulating BTat-mediated transactivation
Q28240747	Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation
Q37586824	Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer
Q28209708	Bromodomain: an acetyl-lysine binding domain
Q28143301	C-terminal domain phosphatase sensitivity of RNA polymerase II in early elongation complexes on the HIV-1 and adenovirus 2 major late templates
Q34353412	CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate
Q35780509	CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo
Q24550765	CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA
Q42812732	CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization
Q39429987	CDK9/cyclin complexes modulate endoderm induction by direct interaction with Mix.3/mixer.
Q59352420	CDK9: a signaling hub for transcriptional control
Q34806667	CTD phosphatase: role in RNA polymerase II cycling and the regulation of transcript elongation
Q41935503	CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes
Q37068686	CTIP2 is a negative regulator of P-TEFb
Q37740906	CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation
Q35067664	Cap-binding protein complex links pre-mRNA capping to transcription elongation and alternative splicing through positive transcription elongation factor b (P-TEFb)
Q36943400	Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells
Q39163015	Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein
Q40696536	Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines
Q40375877	Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation
Q39002029	Cell-free entry of human T-cell leukemia virus type 1 to mouse cells
Q33347964	Cell-type-specific proteome and interactome: using HIV-1 Tat as a test case
Q34465453	Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines
Q33302108	Cellular mRNA activates transcription elongation by displacing 7SK RNA.
Q41818257	Characterization of HIV Tat modifications using novel methyl-lysine-specific antibodies
Q40806871	Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application.
Q106453199	Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor
Q48910832	Characterization of a novel cdk1-related kinase
Q35219724	Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line
Q39548930	Characterization of the Jembrana disease virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats.
Q34283463	Characterization of the influence of mediator complex in HIV-1 transcription
Q34714816	Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy
Q36078954	Chemicals that footprint DNA: hitting HIV-1 in the minor groove
Q27021127	Chromatin, non-coding RNAs, and the expression of HIV
Q38333164	Closing loop base pairs in RNA loop-loop complexes: structural behavior, interaction energy and solvation analysis through molecular dynamics simulations
Q35894061	Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR
Q34408367	Combinatorial Synthesis, Screening, and Binding Studies of Highly Functionalized Polyamino-amido Oligomers for Binding to Folded RNA.
Q43564279	Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses
Q35580831	Comparative Pathogenesis of Epsilonretroviruses
Q37417688	Comparative functional analysis of Jembrana disease virus Tat protein on lentivirus long terminal repeat promoters: evidence for flexibility at its N-terminus
Q24796929	Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs
Q35920526	Complex effects of flavopiridol on the expression of primary response genes
Q33418619	Computational identification of protein methylation sites through bi-profile Bayes feature extraction
Q38800411	Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification
Q54050438	Conditional expression of RNA polymerase II in mammalian cells. Deletion of the carboxyl-terminal domain of the large subunit affects early steps in transcription.
Q36099319	Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.
Q37972643	Control of HIV latency by epigenetic and non-epigenetic mechanisms
Q41941777	Control of Transcriptional Elongation by RNA Polymerase II: A Retrospective
Q28646668	Control of elongation by RNA polymerase II
Q33398516	Control of stochastic gene expression by host factors at the HIV promoter
Q33728518	Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat
Q40863490	Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome
Q30603666	Cooperativity among Rev-associated nuclear export signals regulates HIV-1 gene expression and is a determinant of virus species tropism
Q24559797	Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription
Q28276848	Cracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFb
Q40238292	Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells
Q28236516	Crystal structure of CC3 (TIP30): implications for its role as a tumor suppressor
Q27683254	Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4
Q37645582	Curing HIV: Pharmacologic approaches to target HIV-1 latency
Q89620873	Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
Q38973362	Current views on HIV-1 latency, persistence, and cure.
Q27645094	Cyclin Box Structure of the P-TEFb Subunit Cyclin T1 Derived from a Fusion Complex with EIAV Tat
Q28137611	Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases
Q28579106	Cyclin D3/CDK11(p58) complex involved in Schwann cells proliferation repression caused by lipopolysaccharide
Q33567848	Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase Machinery
Q52543313	Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery.
Q28138707	Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription
Q38003504	Cyclin K goes with Cdk12 and Cdk13
Q42052356	Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells.
Q39681689	Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes
Q34582060	Cyclin T1 overexpression induces malignant transformation and tumor growth
Q33367106	Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors
Q35805077	Cyclin dependent kinase 11 in RNA transcription and splicing
Q54216878	Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Q35038779	Cyclin-dependent kinases as new targets for the prevention and treatment of cancer
Q41138339	DDX6 transfers P-TEFb kinase to the AF4/AF4N (AFF1) super elongation complex
Q30672419	DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes
Q28139929	DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation
Q35911735	Dark matter RNA: an intelligent scaffold for the dynamic regulation of the nuclear information landscape
Q37487966	Defining NELF-E RNA binding in HIV-1 and promoter-proximal pause regions
Q34267043	Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences
Q41175211	Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA.
Q42004076	Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation.
Q32173424	Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies
Q40817567	Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle
Q24684924	Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription
Q36296748	Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity
Q39693187	Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF
Q40642204	Differential activation of Tat variants in mitogen-stimulated cells: implications for HIV-1 postintegration latency
Q41789287	Differential chromatin looping regulates CD4 expression in immature thymocytes
Q33819734	Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes
Q36419687	Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes
Q24293249	Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity
Q38739211	Distinct conformational transition patterns of noncoding 7SK snRNA and HIV TAR RNAs upon Tat binding
Q44264374	Distinct regions of cyclinT1 are required for binding to CDK9 and for recruitment to the HIV-1 Tat/TAR complex.
Q34816193	Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system
Q24554258	Domains in the SPT5 protein that modulate its transcriptional regulatory properties
Q41320056	Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.
Q28202607	Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin
Q36555327	Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model
Q55314057	Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.
Q40024356	Drosophila Pgc protein inhibits P-TEFb recruitment to chromatin in primordial germ cells
Q35128809	Dynamic transcriptional events in embryonic stem cells mediated by the super elongation complex (SEC).
Q28646726	Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element
Q38756296	Dynamics of nascent mRNA folding and RNA-protein interactions: an alternative TAR RNA structure is involved in the control of HIV-1 mRNA transcription
Q34404828	Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity
Q40945385	Effect of Cocaine on Pulmonary Vascular Remodeling and Hemodynamics in Human Immunodeficiency Virus-Transgenic Rats
Q35040154	Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription
Q39549994	Effect of transcription peptide inhibitors on HIV-1 replication
Q35075250	Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern India
Q37409631	Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice
Q33953076	Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
Q34510011	Efficient in silico exploration of RNA interhelical conformations using Euler angles and WExplore
Q41859093	Efficient transcription of the EBER2 gene depends on the structural integrity of the RNA.
Q39668496	Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.
Q34877762	Epigenetic heterogeneity in HIV-1 latency establishment
Q39933477	Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency
Q35252186	Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Q42068689	Evidence for a base triple in the free HIV-1 TAR RNA.
Q42831352	Evidence for conformational flexibility in the Tat-TAR recognition motif of cyclin T1.
Q22008559	Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro
Q28742565	Evolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replication
Q39549399	Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
Q35462419	Evolutionary distance of amino acid sequence orthologs across macaque subspecies: identifying candidate genes for SIV resistance in Chinese rhesus macaques
Q33866139	Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-
Q40676905	Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.
Q36466170	Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA
Q38702490	Exosomes from uninfected cells activate transcription of latent HIV-1.
Q37369645	Exploiting features of adenovirus replication to support mammalian kinase production
Q31068120	Expression of Arabidopsis SR-like splicing proteins confers salt tolerance to yeast and transgenic plants
Q37209394	Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.
Q33707390	Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion
Q36283854	FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency
Q22003918	FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO
Q91959762	Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery
Q28585216	Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development
Q41741183	Fitting peptides into the RNA world
Q34082542	Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo
Q33910799	Flavopiridol inhibits P-TEFb and blocks HIV-1 replication
Q33832656	Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials
Q45316602	Formation of HIV-1 elongation complex containing HIV-1 Tat
Q84044756	Formation of Tat-TAR containing ribonucleoprotein complexes for biochemical and structural analyses
Q50289424	Formation of the P-TEFb(Cyclin T1:Cdk9) complex
Q39395490	Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1.
Q39591095	Functional differences between human and bovine immunodeficiency virus Tat transcription factors
Q39590547	Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Q33654155	Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription.
Q37368973	Functional evolution of cyclin-dependent kinases.
Q54762582	Functional inactivation of Cdk9 through oligomerization chain reaction.
Q42513599	Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells
Q28140346	Functional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cells
Q39550602	Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2.
Q34869767	G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).
Q36071452	Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats.
Q33936233	Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.
Q35842547	Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription
Q33947277	Genetic analysis of the structure and function of 7SK small nuclear ribonucleoprotein (snRNP) in cells
Q35207524	Genetic therapy for HIV/AIDS.
Q92135927	Genetic variation and function of the HIV-1 Tat protein
Q34991865	Genetically-modified-animal models for human infections: the Listeria paradigm
Q42755157	Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription.
Q45869361	Genomic organization and characterization of promoter function of the human CDK9 gene
Q40470271	Granulin and granulin repeats interact with the Tat.P-TEFb complex and inhibit Tat transactivation.
Q46689072	HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation
Q35829330	HEXIM1 is a promiscuous double-stranded RNA-binding protein and interacts with RNAs in addition to 7SK in cultured cells.
Q37226490	HEXIM1, a New Player in the p53 Pathway
Q58612091	HEXIM1-Tat chimera inhibits HIV-1 replication
Q24294998	HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK
Q26746070	HIV Genome-Wide Protein Associations: a Review of 30 Years of Research
Q35088029	HIV Tat, its TARgets and the control of viral gene expression
Q52577483	HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies.
Q34935285	HIV and hepatitis delta virus: evolution takes different paths to relieve blocks in transcriptional elongation
Q37974218	HIV latency
Q40361663	HIV latency: present knowledge, future directions
Q78128370	HIV recent advances in AIDS research: genetics, molecular biology and immunology
Q26995784	HIV restriction in quiescent CD4⁺ T cells
Q33292300	HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1.
Q40352274	HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells
Q39134277	HIV-1 Tat and Viral Latency: What We Can Learn from Naturally Occurring Sequence Variations.
Q34896128	HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription
Q39703646	HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP
Q37518169	HIV-1 Tat directly binds to NFkappaB enhancer sequence: role in viral and cellular gene expression
Q24564896	HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses
Q40016960	HIV-1 Tat inhibits NGF-induced Egr-1 transcriptional activity and consequent p35 expression in neural cells
Q44061963	HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter
Q41675687	HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA.
Q33940354	HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA.
Q30436450	HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum
Q28215081	HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110
Q40727461	HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription
Q42767857	HIV-1 Tat: Its Dependence on Host Factors is Crystal Clear
Q33711447	HIV-1 Tat: coping with negative elongation factors
Q47555826	HIV-1 Vif's capacity to manipulate the cell cycle is species-specific
Q47964324	HIV-1 auxiliary proteins: making connections in a dying cell
Q21245215	HIV-1 gene expression: lessons from provirus and non-integrated DNA
Q38204866	HIV-1 latency: an update of molecular mechanisms and therapeutic strategies
Q35166833	HIV-1 pathogenesis
Q37607912	HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes
Q38273477	HIV-1 replication and latency are regulated by translational control of cyclin T1
Q22007982	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter
Q77891434	HIV-1 transcription: activation mediated by acetylation of Tat
Q51981129	HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation.
Q36407266	HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.
Q36901782	HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription
Q27469600	Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding
Q45395775	Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells
Q35058535	Hide, shield and strike back: how HIV-infected cells avoid immune eradication
Q34291018	High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier
Q38808207	High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis.
Q39446082	Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism
Q38357741	Histone deacetylase 6 in health and disease
Q37086989	Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9.
Q59357225	Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1
Q33455551	Host cell factors in HIV replication: meta-analysis of genome-wide studies
Q36390969	Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication
Q28243562	Hsp90: a chaperone for HIV-1
Q36363829	Human CRM1 augments production of infectious human and feline immunodeficiency viruses from murine cells
Q24307731	Human DDX3 interacts with the HIV-1 Tat protein to facilitate viral mRNA translation
Q33850701	Human GLI-2 is a tat activation response element-independent Tat cofactor
Q40967217	Human T-cell leukemia virus type 1 can infect a wide variety of cells in mice
Q39629705	Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infection
Q89522955	Human Tat-specific factor 1 binds the HIV-1 genome and selectively transports HIV-1 RNAs
Q33815080	Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate
Q33825196	Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.
Q34545610	Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1.
Q42829649	Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity
Q43193366	Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.
Q36330062	Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication
Q33863026	Human immunodeficiency virus Tat associates with a specific set of cellular RNAs
Q33809273	Human immunodeficiency virus and AIDS: insights from animal lentiviruses
Q33541775	Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.
Q24564662	Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression
Q40004324	Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation
Q39612144	Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process
Q45723766	Human immunodeficiency virus type 1 envelope-mediated neuropathogenesis: targeted gene delivery by a Sindbis virus expression vector
Q41039158	Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages.
Q39685140	Human immunodeficiency virus type 1 nucleocapsid protein nuclear localization mediates early viral mRNA expression
Q40679108	Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E.
Q39595632	Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR
Q35906138	Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65.
Q24310867	Human mediator subunit MED26 functions as a docking site for transcription elongation factors
Q35168345	Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.
Q56795003	Identification of Limiting Steps for Efficient Trans-activation of HIV-1 Promoter by Tat inSaccharomyces cerevisiae
Q39611074	Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation
Q28247078	Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat
Q24317025	Identification of multiple cyclin subunits of human P-TEFb
Q41457054	Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent
Q34527341	Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction
Q37034627	Identification of potential drug targets using genomics and proteomics: a systems approach
Q38714324	Imaging HIV-1 Genomic DNA from Entry through Productive Infection
Q26782046	Impact of Chromatin on HIV Replication
Q36148507	Impact of Tat Genetic Variation on HIV-1 Disease
Q40541599	Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway
Q36805433	Improving HIV proteome annotation: new features of BioAfrica HIV Proteomics Resource
Q52808328	In cell mutational interference mapping experiment (in cell MIME) identifies the 5' polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging.
Q28211352	In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA
Q38291138	In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes
Q39324883	In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cells
Q35066359	In vivo SELEX of single-stranded domains in the HIV-1 leader RNA.
Q30439541	Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula
Q42554535	Indirubin 3'-monoxime, from a Chinese traditional herbal formula, suppresses viremia in humanized mice infected with multidrug-resistant HIV
Q40414692	Induction of OGG1 gene expression by HIV-1 Tat.
Q33849629	Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines
Q21245103	Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content
Q35073696	Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1.
Q35192970	Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway.
Q77219939	Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog
Q53909022	Inhibition of HIV-1 replication by cell-penetrating peptides binding Rev.
Q36850296	Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.
Q45049610	Inhibition of HIV-1 virus replication using small soluble Tat peptides
Q24298519	Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA
Q36915824	Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors
Q31115718	Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies
Q28478188	Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA
Q35036496	Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Q36954414	Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
Q39470193	Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells
Q28343602	Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species
Q28344365	Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors
Q33780297	Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Q39139534	Inhibitory function of adapter-related protein complex 2 alpha 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome
Q37354566	Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex
Q39676027	Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes
Q24548261	Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome
Q33890579	Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding
Q39601983	Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells
Q73408185	Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners
Q39581386	Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein
Q38358056	Interaction of the porcine reproductive and respiratory syndrome virus nucleocapsid protein with the inhibitor of MyoD family-a domain-containing protein
Q39589026	Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.
Q34987620	Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T
Q45316630	Interactions of Tat with host cellular proteins
Q79745144	Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis
Q28217472	Interplay between cdk9 and NF-kappaB factors determines the level of HIV-1 gene transcription in astrocytic cells
Q39921503	Intragenic transcriptional cis-activation of the human immunodeficiency virus 1 does not result in allele-specific inhibition of the endogenous gene
Q33853960	Invisible RNA state dynamically couples distant motifs
Q34171674	Involvement of cyclin K posttranscriptional regulation in the formation of Artemia diapause cysts
Q36143645	Iron chelators ICL670 and 311 inhibit HIV-1 transcription
Q36005484	Isolation and characterization of mouse-human microcell hybrid cell clones permissive for infectious HIV particle release
Q47844049	Isolation and characterization of the human cyclin T1 promoter
Q40852764	Isolation of Cognate Cellular and Viral Ribonucleoprotein Complexes of HIV-1 RNA Applicable to Proteomic Discovery and Molecular Investigations.
Q35131684	Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection
Q28376959	Isoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latency
Q89673835	JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes
Q33799971	Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication
Q84654190	Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion
Q24646322	LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated
Q25255905	Latency: the hidden HIV-1 challenge
Q47098902	Latent HIV-1 TAR Regulates 7SK-responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat.
Q36155046	Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.
Q34452109	Lentivirus and foamy virus vectors: novel gene therapy tools
Q34754954	Lentiviruses as gene transfer agents for delivery to non-dividing cells
Q35012861	Linking cyclins to transcriptional control.
Q27651054	Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex
Q37010047	Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation
Q34075254	Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription
Q39804456	Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts
Q38091888	Lost in transcription: molecular mechanisms that control HIV latency
Q37583411	Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA
Q36699534	Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR.
Q24679741	MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner
Q36274198	MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding
Q35597624	MYB elongation is regulated by the nucleic acid binding of NFκB p50 to the intronic stem-loop region.
Q41927990	Making Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription
Q38212042	Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages.
Q40118214	Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.
Q37822089	Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise
Q28140555	Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style
Q34987465	Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells.
Q40670620	Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.
Q33680820	Mechanism and regulation of transcriptional elongation by RNA polymerase II.
Q41769072	Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency
Q33815611	Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse
Q24558697	Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression
Q34730602	Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy
Q21146658	Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
Q61800035	Modeling the Function of TATA Box Binding Protein in Transcriptional Changes Induced by HIV-1 Tat in Innate Immune Cells and the Effect of Methamphetamine Exposure
Q24808657	Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5
Q55405435	Molecular Mechanisms of Injury in HIV-Associated Nephropathy.
Q42836979	Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication
Q38310688	Molecular beacon aptamer fluoresces in the presence of Tat protein of HIV-1.
Q54441914	Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5.
Q40374329	Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors.
Q28544421	Molecular dynamics simulation and experimental verification of the interaction between cyclin T1 and HIV-1 Tat proteins
Q36515063	Molecular mechanisms of HIV latency
Q33864438	Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage
Q36278085	Molecular mechanisms of HIV-1 proviral latency
Q36916993	Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration
Q33837992	Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly
Q33743566	Multifaceted activities of the HIV-1 transactivator of transcription, Tat.
Q47555946	Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature
Q34033118	Multiple biological roles associated with the repeat (R) region of the HIV-1 RNA genome
Q33603453	Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells
Q35914370	Multiple restrictions of human immunodeficiency virus type 1 in feline cells
Q47822116	Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
Q39094752	Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA
Q35868299	Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression
Q42811398	Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter
Q30977476	NKIAMRE, a novel conserved CDC2-related kinase with features of both mitogen-activated protein kinases and cyclin-dependent kinases
Q30909558	NMR characterization of a kissing complex formed between the TAR RNA element of HIV-1 and a DNA aptamer
Q33602605	Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat
Q39323907	Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression
Q35749130	Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline
Q21198772	New insights into HIV-1-primary skin disorders
Q34919381	New insights into the control of HIV-1 transcription: when Tat meets the 7SK snRNP and super elongation complex (SEC).
Q35122702	New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade
Q42239136	New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5' end of the HIV-2 leader RNA.
Q49455798	Non-Coding RNAs As Transcriptional Regulators In Eukaryotes
Q49236374	Non-coding RNAs and retroviruses.
Q35772862	Noncoding RNA localisation mechanisms in chromatin regulation
Q30885539	Novel bovine lentiviral vectors based on Jembrana disease virus
Q37547409	Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication
Q35635000	Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells
Q28177130	Nuclear protein phosphatase-1 regulates HIV-1 transcription
Q34101377	Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex
Q37866370	Nuclear remodelling during viral infections
Q25255186	Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb
Q33178132	Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
Q39308951	Opening of the TAR hairpin in the HIV-1 genome causes aberrant RNA dimerization and packaging
Q39685303	Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression
Q39135199	Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6.
Q89782162	P-TEFb as A Promising Therapeutic Target
Q26741360	P-TEFb goes viral
Q38896947	P-TEFb goes viral.
Q29620167	P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
Q37356131	P-TEFb- the final frontier
Q40272529	PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription
Q36174095	PPM1G Binds 7SK RNA and Hexim1 To Block P-TEFb Assembly into the 7SK snRNP and Sustain Transcription Elongation.
Q34650866	Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective
Q33649755	Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems
Q34343774	Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins
Q46675052	Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA.
Q28487524	Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes
Q35805406	Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression
Q24806541	Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription
Q24537588	Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation
Q31072762	Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle
Q28143919	Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation
Q28114798	Physical interaction between pRb and cdk9/cyclinT2 complex
Q34973763	Polo-like kinase 1 inhibits the activity of positive transcription elongation factor of RNA Pol II b (P-TEFb).
Q40501267	Poly(ADP-ribose) polymerase-1 is a negative regulator of HIV-1 transcription through competitive binding to TAR RNA with Tat.positive transcription elongation factor b (p-TEFb) complex
Q33708590	Polyamide Amino Acids trimers as TAR RNA ligands and anti-HIV agents
Q31807459	Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.
Q39682296	Positive transcription elongation factor b (P-TEFb) contributes to dengue virus-stimulated induction of interleukin-8 (IL-8).
Q35076669	Postentry restriction of Mason-Pfizer monkey virus in mouse cells
Q40073989	Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
Q30879123	Potent inhibition of HIV-1 replication by a Tat mutant
Q33814620	Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy
Q36821394	Premature termination of transcription by RNAP II: the beginning of the end.
Q35980829	Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression
Q73182068	Principles and applications of a Tat-based assay for analyzing specific RNA-protein interactions in mammalian cells
Q39704599	Productive replication of Vif-chimeric HIV-1 in feline cells
Q41815313	Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters
Q36370241	Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.
Q35633540	Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge
Q34654219	Properties of RNA polymerase II elongation complexes before and after the P-TEFb-mediated transition into productive elongation.
Q41683241	Protein and RNA affinity selection techniques using HIV-1 Tat.
Q37950254	Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.
Q24318492	Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages
Q38293944	Proteomics in the investigation of HIV-1 interactions with host proteins
Q40669160	Quantification of the HIV transcriptional activator complex in live cells by image-based protein-protein interaction analysis
Q40140632	Quantitative analysis of RNA-mediated protein-protein interactions in living cells by FRET.
Q41918740	Quiescence promotes latent HIV infection and resistance to reactivation from latency with histone deacetylase inhibitors
Q39550188	R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs.
Q29540749	RNA Polymerase II C-Terminal Domain: Tethering Transcription to Transcript and Template
Q39685491	RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication
Q42027880	RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation
Q40069803	Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.
Q37305160	Reactivation of latent HIV-1 in central memory CD4⁺ T cells through TLR-1/2 stimulation
Q40108650	Real-time visualization of chromatin modification in isolated nuclei.
Q33633451	Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders
Q33958031	Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.
Q24515333	Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.
Q33269333	Recruitment and activation of RSK2 by HIV-1 Tat
Q42181127	Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency
Q40990135	Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.
Q37191856	Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription
Q36405698	Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription
Q24675942	Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein
Q37553804	Regulation of CDK9 activity by phosphorylation and dephosphorylation.
Q33769035	Regulation of HIV-1 transcription
Q33593821	Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression
Q34685118	Regulation of Tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6.
Q28289216	Regulation of carboxyl-terminal domain phosphatase by HIV-1 tat protein
Q35826285	Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes.
Q30350982	Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
Q40335491	Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding
Q40236968	Regulation of the Alternative Splicing and Function of Cyclin T1 by the Serine-Arginine-Rich Protein ASF/SF2.
Q34816680	Regulation of transcription elongation by phosphorylation
Q36571363	Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.
Q24552532	Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter
Q33940913	Renal HIV expression is unaffected by serum LPS levels in an HIV transgenic mouse model of LPS induced kidney injury
Q37099750	Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells
Q34467420	Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions
Q34263935	Repression of MHC determinants in HIV infection
Q24315665	Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter
Q28141637	Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription
Q43416969	Reservoirs for HIV-1.
Q38610855	Resveratrol, sirtuins, and viruses
Q35836276	Retroviral mRNA nuclear export elements regulate protein function and virion assembly.
Q37183096	Retroviral proteomics and interactomes: intricate balances of cell survival and viral replication
Q37895742	Retroviral restriction and dependency factors in primates and carnivores
Q58700378	Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization
Q39577905	Ribosomal scanning on the 5'-untranslated region of the human immunodeficiency virus RNA genome
Q27486874	Ring Expanded Nucleoside Analogues Inhibit RNA Helicase and Intracellular Human Immunodeficiency Virus Type 1 Replication
Q38430337	Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription
Q40945481	Role of RNA polymerase II carboxy-terminal domain in coordinating transcription with RNA processing
Q34033128	Role of chromatin in HIV-1 transcriptional regulation
Q37631411	Role of noncoding RNAs in the regulation of P-TEFb availability and enzymatic activity
Q26996314	Roles and functions of HIV-1 Tat protein in the CNS: an overview
Q28286819	Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions
Q24797263	SIRT1 regulates HIV transcription via Tat deacetylation
Q39855918	SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1.
Q33990712	SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA
Q37472861	Sam68 functions in nuclear export and translation of HIV-1 RNA.
Q30651338	Screening RNA-binding libraries using Tat-fusion system in mammalian cells
Q51868929	Screening strategies to identify host factors associated with the early and late stages of HIV-1 life cycle.
Q40439853	Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1.
Q33196801	Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system
Q37437860	Selective control of gene expression by CDK9 in human cells
Q59354479	Semen exosomes promote transcriptional silencing of HIV-1 by disrupting NF-kB/Sp1/Tat circuitry
Q24527316	Sequence and transcriptional analyses of the fish retroviruses walleye epidermal hyperplasia virus types 1 and 2: evidence for a gene duplication.
Q30870026	Sequence of goat cyclin T1 cDNA, gene organisation and expression analysis
Q34656952	Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications
Q34293568	Small molecule modulators of cyclin-dependent kinases for cancer therapy
Q33824990	Species-specific, postentry barriers to primate immunodeficiency virus infection
Q93010915	Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy
Q36675349	Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter
Q35059684	Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription
Q39016210	Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5'-LTR promoter
Q24537527	Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences
Q35761279	Squamous epithelial proliferation induced by walleye dermal sarcoma retrovirus cyclin in transgenic mice
Q37352913	Stable pausing by RNA polymerase II provides an opportunity to target and integrate regulatory signals
Q37137908	Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication
Q42468627	Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer
Q35107931	Stimulation of Tat-independent transcriptional processivity from the HIV-1 LTR promoter by matrix attachment regions
Q28214807	Stimulatory effect of splicing factors on transcriptional elongation
Q33835795	Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat.
Q27638717	Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain
Q24632055	Structural determinants and mechanism of HIV-1 genome packaging
Q27652984	Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV
Q58762403	Structural insights into the functional diversity of the CDK-cyclin family
Q90258885	Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex
Q27622070	Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B
Q77914240	Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling
Q22009021	Structure and function of the human transcription elongation factor DSIF
Q59070952	Structure of activated transcription complex Pol II–DSIF–PAF–SPT6
Q96431678	Structure of complete Pol II-DSIF-PAF-SPT6 transcription complex reveals RTF1 allosteric activation
Q59087446	Structure of paused transcription complex Pol II-DSIF-NELF
Q34449437	Structure-based design of a dimeric RNA-peptide complex
Q40275061	Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb
Q37101393	Suppression of HIV-1 Nef translation by Sam68 mutant-induced stress granules and nef mRNA sequestration
Q38356107	Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences
Q39545943	Surface plasmon resonance kinetic studies of the HIV TAR RNA kissing hairpin complex and its stabilization by 2-thiouridine modification
Q34976301	Susceptibility of Mink ( Mustera vision )-Derived Cells to Replication by Human Immunodeficiency Virus Type 1
Q39606789	Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.
Q39852737	Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages
Q34796643	Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity
Q35091855	Systematic approaches towards the development of host-directed antiviral therapeutics
Q35613792	T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention
Q35113716	T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway
Q34030432	TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication
Q41852627	TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
Q28188877	TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription
Q24600874	TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes
Q24304062	TRIM5α and Species Tropism of HIV/SIV
Q39724730	Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression.
Q40079572	Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice
Q35910232	Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice
Q54210140	Targeting the Latent Reservoir for HIV-1.
Q28214887	Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication
Q33957746	Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase
Q34161703	Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1.
Q34033142	Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
Q35993736	Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine
Q28144181	Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
Q54254325	Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.
Q90292108	Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression
Q28116305	Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription
Q34156984	Tat stimulates cotranscriptional capping of HIV mRNA.
Q78873851	Tat's seductive side
Q33455685	Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs
Q22003803	Tat-SF1 protein associates with RAP30 and human SPT5 proteins
Q28138220	Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes
Q33786066	Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines
Q45316601	Tat-mediated elongation of the HIV-1 transcript
Q44720095	Techniques to analyze the HIV-1 Tat and TAR RNA-dependent recruitment and activation of the cyclin T1: CDK9 (P-TEFb) transcription elongation factor.
Q41510614	The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes
Q28206012	The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription
Q27676733	The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat
Q41862317	The Brome mosaic virus subgenomic promoter hairpin is structurally similar to the iron-responsive element and functionally equivalent to the minus-strand core promoter stem-loop C.
Q39777846	The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription.
Q40731101	The HIV-1 Tat Protein Is Monomethylated at Lysine 71 by the Lysine Methyltransferase KMT7
Q24596637	The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor
Q38286131	The HIV-1 Tat protein has a versatile role in activating viral transcription
Q54977707	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.
Q40135003	The HIV-1 Tat protein: mechanism of action and target for HIV-1 cure strategies.
Q36578522	The HIV-1 transgenic rat model of neuroHIV.
Q33893725	The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly
Q34382921	The MHC class II transactivator: prey and hunter in infectious diseases
Q38043907	The Mediator complex and transcription elongation
Q37027897	The N-end rule and retroviral infection: no effect on integrase
Q91661378	The Per-1 Short Isoform Inhibits de novo HIV-1 Transcription in Resting CD4+ T-cells
Q34654513	The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells
Q42117931	The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency
Q47824549	The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein.
Q42431758	The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription
Q35829282	The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
Q35973578	The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
Q42508685	The Werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication
Q35072999	The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation
Q39580108	The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.
Q28189849	The apical loop of the HIV-1 TAR RNA hairpin is stabilized by a cross-loop base pair
Q28254964	The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1
Q24316236	The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
Q35188989	The carboxyl terminus of phage HK022 Nun includes a novel zinc-binding motif and a tryptophan required for transcription termination.
Q37958430	The control of HIV transcription: keeping RNA polymerase II on track
Q36906001	The effects of cocaine on HIV transcription
Q39005055	The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
Q24298498	The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression
Q24554329	The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription
Q28198162	The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat
Q24307870	The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription
Q24318776	The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription
Q33805882	The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging
Q35211232	The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein
Q34362436	The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure
Q21136168	The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK
Q34544409	The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit
Q28143137	The nuclear receptor chicken ovalbumin upstream promoter transcription factor interacts with HIV-1 Tat and stimulates viral replication in human microglial cells
Q28595060	The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2
Q28251761	The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention
Q39580918	The secondary structure of the R region of a murine leukemia virus is important for stimulation of long terminal repeat-driven gene expression.
Q24323313	The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation
Q36119592	The transcriptional cycle of HIV-1 in real-time and live cells.
Q40951736	The transcriptional inhibitors, actinomycin D and alpha-amanitin, activate the HIV-1 promoter and favor phosphorylation of the RNA polymerase II C-terminal domain
Q33700143	The transcriptional transactivator Tat selectively regulates viral splicing.
Q30413065	The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells
Q33957637	The yeast C-type cyclin Ctk2p is phosphorylated and rapidly degraded by the ubiquitin-proteasome pathway
Q34133579	Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities
Q28208318	Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences
Q37428613	Tip110 protein binds to unphosphorylated RNA polymerase II and promotes its phosphorylation and HIV-1 long terminal repeat transcription
Q44018972	Topoisomerase I and ATP activate cDNA synthesis of human immunodeficiency virus type 1.
Q37194356	Transcription elongation control by the 7SK snRNP complex: Releasing the pause.
Q24533266	Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages
Q39069527	Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication.
Q41853689	Transcription factors mediate the enzymatic disassembly of promoter-bound 7SK snRNP to locally recruit P-TEFb for transcription elongation.
Q36857070	Transcription of HIV: Tat and cellular chromatin
Q40856625	Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
Q34030804	Transcriptional and posttranscriptional regulation of HIV-1 gene expression
Q24554483	Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner
Q33591923	Transcriptional control by cell-cycle regulators: a review
Q26999858	Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure
Q28275557	Transcriptional control: Tat cofactors and transcriptional elongation
Q34443670	Transcriptional interference antagonizes proviral gene expression to promote HIV latency
Q44786579	Transcriptional pausing at +62 of the HIV-1 nascent RNA modulates formation of the TAR RNA structure
Q35155025	Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir
Q40932318	Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo
Q34620906	Transcriptional regulation of HIV-1 gene expression by p53.
Q35186960	Transcriptional repression by the Caenorhabditis elegans germ-line protein PIE-1.
Q24534907	Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain
Q37690181	Transfection of nerve cells.
Q37398621	Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cells
Q39685314	Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
Q39272683	Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
Q34381967	Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein
Q40190265	Two G-rich regulatory elements located adjacent to and 440 nucleotides downstream of the core poly(A) site of the intronless melanocortin receptor 1 gene are critical for efficient 3' end processing
Q34363290	Two alternating structures of the HIV-1 leader RNA
Q77716325	Ubiquitous expression of goat cyclin T1 in transgenic mice
Q33930482	Ubiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation
Q47695033	Unexpected high testis-specific transcriptional activity of the cyclin T1 promoter in transgenic mice
Q36202709	Use of ATP analogs to inhibit HIV-1 transcription
Q45416488	Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challenge
Q83393426	Viral RNAs: lessons from the enemy
Q33920746	Viral cyclins
Q34104253	Viral replication and the coactivators p300 and CBP.
Q35026881	Viral-host interactions that control HIV-1 transcriptional elongation
Q24813634	Virus-host interactions: new insights from the small RNA world.
Q40786197	Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer
Q35121356	Visualization of positive transcription elongation factor b (P-TEFb) activation in living cells
Q33785258	Walleye retroviruses associated with skin tumors and hyperplasias encode cyclin D homologs.
Q33400343	Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription
Q35034218	ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter
Q55360108	Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells.
Q38295485	c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism
Q28204153	c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis
Q24629119	c-Myc regulates transcriptional pause release
Q30479670	iRED analysis of TAR RNA reveals motional coupling, long-range correlations, and a dynamical hinge
Q35641069	p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation
Q33292132	p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.
Q36827396	tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

P356	DOI	10.1016/S0092-8674(00)80939-3
P3181	OpenCitations bibliographic resource ID	126446
P698	PubMed publication ID	9491887

P50	author	Fang Zhouzi	Q633818
P2093	author name string	P Wei
		K A Jones
		W H Fischer
		S M Fang
		M E Garber
P2860	cites work	Major determinants of the specificity of interaction between small nuclear ribonucleoproteins U1A and U2B'' and their cognate RNAs	Q45188961
		Pch1(+), a second essential C-type cyclin gene in Schizosaccharomyces pombe.	Q46000120
		Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase	Q46760600
		Purification of P-TEFb, a transcription factor required for the transition into productive elongation.	Q52539193
		Mechanism and regulation of transcriptional elongation and termination by RNA polymerase II	Q63384164
		Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex	Q24568316
		Novel mechanism and factor for regulation by HIV-1 Tat	Q24568366
		The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme	Q24646774
		Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor	Q24676286
		Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin	Q27730785
		A kinase-cyclin pair in the RNA polymerase II holoenzyme.	Q27930481
		The yeast carboxyl-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex	Q27932742
		Modulation of RNA polymerase II elongation efficiency by C-terminal heptapeptide repeat domain kinase I.	Q27934205
		A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase	Q28247022
		A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer	Q28271385
		Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat	Q28292698
		CDK-independent activation of estrogen receptor by cyclin D1	Q28304020
		Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes	Q28304889
		P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro	Q28379179
		TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines	Q28647556
		Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro	Q29614788
		Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase	Q29614789
		PEST sequences and regulation by proteolysis	Q29616394
		Control of RNA initiation and elongation at the HIV-1 promoter	Q29620157
		Stress and developmental regulation of the yeast C-type cyclin Ume3p (Srb11p/Ssn8p).	Q33887194
		Nuclear translocation and carboxyl-terminal domain phosphorylation of RNA polymerase II delineate the two phases of zygotic gene activation in mammalian embryos	Q34250244
		Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin	Q34631467
		Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.	Q38313551
		The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence	Q38324797
		Control of formation of two distinct classes of RNA polymerase II elongation complexes.	Q38329037
		Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex	Q38342881
		Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.	Q40041905
		Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR.	Q40045425
		TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12.	Q40046655
		RNA-protein interactions. Diverse modes of recognition	Q40401623
		News on initiation and elongation of transcription by RNA polymerase II.	Q40475471
		A weak interaction between the U2A' protein and U2 snRNA helps to stabilize their complex with the U2B" protein	Q40531081
		RNA recognition by the human immunodeficiency virus Tat and Rev proteins	Q40767437
		Does HIV-1 Tat induce a change in viral initiation rights?	Q40905875
		The U2B'' RNP motif as a site of protein-protein interaction.	Q41230779
		Taking a new TAK on tat transactivation	Q41614227
		Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase.	Q43447901
		High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region	Q43480910
P433	issue	4
P407	language of work or name	English	Q1860
P921	main subject	HIV	Q15787
P304	page(s)	451-62
P577	publication date	1998-02-20
P1433	published in	Cell	Q655814
P1476	title	A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
P478	volume	92

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

scientific article

Reverse relations